Search results
EMA approves Sanofi’s Dupixent for COPD treatment in adults
Pharmaceutical Technology· 1 day agoThe European Medicines Agency (EMA) has approved Sanofi's Dupixent (dupilumab) as the first targeted...
How can (A)I help? AI chatbot to help understand the world of AI regulation
Clinical Trials Arena· 11 hours agoThe European Medicines Agency (EMA) has also released draft guidance on the use of AI in the...
Ahead of Market: 10 things that will decide D-Street action on Friday
The Economic Times· 4 hours agoWhile the Nifty's overall trend appears positive across different time frames, it is currently...
EMA CHMP recommends approval for Roche’s PNH therapy
Pharmaceutical Technology· 3 days agoThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting approval in the European Union...
EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
Pharmaceutical Technology· 2 days agoThe European Medicines Agency (EMA) has accepted AstraZeneca's marketing authorisation application...
Vraj Iron & Steel Share Price Today: Live NSE/BSE Vraj Iron & Steel Stock Price, Performance,...
Financial Express· 38 minutes agoVraj Iron & Steel Ltd., operating in the Iron & Steel sector and classified as a Smallcap on the bse, currently has its share price at 264.5 The stock has experienced fluctuations today, with ...
Biocon Biologics Receives EMA Approval to Manufacture Bevacizumab in India
SiliconIndia· 6 days agoTeam siliconindiaBiocon Biologics, a subsidiary of Biocon, received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India. This ...
Stock market today: Trade setup for Nifty 50 to US Fed meeting, experts recommend five stocks to buy...
Livemint· 18 hours agoStock market today: Following strong global market sentiments on the US Fed rate cut buzz, the...
Johnson & Johnson gains FDA and EC approvals for TB treatment
Pharmaceutical Technology· 1 day agoJ&J submitted a supplemental New Drug Application to the FDA in August 2023 and a Type II variation...
Trading Plan: Will Nifty, Bank Nifty consolidate before showing another leg of upmove?
CNBC Awaaz· 1 hour agoThe Nifty 50 may consolidate further with a hurdle at 24,400-24,500 on the higher side, while...